Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0419 | 0.0983 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.012 | 0.4525 | 1 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0071 | 0.2364 | 0.2364 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0003 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.0114 | 0.4256 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0814 | 0.0814 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.0114 | 0.4256 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0026 | 0.0419 | 0.0925 |
Brugia malayi | vesicle-fusing ATPase | 0.0071 | 0.2364 | 0.2364 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.012 | 0.4525 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0051 | 0.1515 | 0.1515 |
Brugia malayi | isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0001 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0051 | 0.1515 | 0.1515 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0026 | 0.0419 | 0.0983 |
Echinococcus multilocularis | isocitrate dehydrogenase 2 (NADP+) | 0.0016 | 0.0001 | 0.0003 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0122 | 0.4607 | 0.4607 |
Mycobacterium tuberculosis | Putative conserved ATPase | 0.0072 | 0.2427 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.1515 | 0.1515 |
Entamoeba histolytica | cdc48-like protein, putative | 0.0114 | 0.4256 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0419 | 0.0983 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0026 | 0.0419 | 0.0983 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0072 | 0.2427 | 0.5361 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.0114 | 0.4256 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0114 | 0.4256 | 0.9405 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.012 | 0.4525 | 1 |
Toxoplasma gondii | cell division protein CDC48CY | 0.012 | 0.4525 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0026 | 0.0419 | 0.0983 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0035 | 0.0814 | 0.0814 |
Brugia malayi | valosin containing protein | 0.0071 | 0.2364 | 0.2364 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0003 |
Brugia malayi | Isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0001 |
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.0114 | 0.4256 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0122 | 0.4607 | 0.4607 |
Loa Loa (eye worm) | hypothetical protein | 0.0155 | 0.6018 | 0.6018 |
Schistosoma mansoni | NADP-specific isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0003 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0246 | 1 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0122 | 0.4607 | 0.4607 |
Echinococcus multilocularis | isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0003 |
Onchocerca volvulus | 0.0246 | 1 | 1 | |
Brugia malayi | transitional endoplasmic reticulum ATPase TER94, putative | 0.005 | 0.146 | 0.146 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0051 | 0.1515 | 0.1515 |
Loa Loa (eye worm) | isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0001 |
Echinococcus multilocularis | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0003 |
Mycobacterium ulcerans | ATPase | 0.0072 | 0.2427 | 0.5 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.0114 | 0.4256 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0026 | 0.0419 | 0.0983 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.2364 | 0.2364 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0814 | 0.1799 |
Toxoplasma gondii | transitional endoplasmic reticulum ATPase, putative | 0.0072 | 0.2427 | 0.5361 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.005 | 0.146 | 0.3226 |
Brugia malayi | hypothetical protein | 0.0017 | 0.0022 | 0.0022 |
Plasmodium vivax | cell division cycle ATPase, putative | 0.0044 | 0.1191 | 0.2796 |
Brugia malayi | hypothetical protein | 0.0155 | 0.6018 | 0.6018 |
Brugia malayi | hypothetical protein | 0.0026 | 0.0419 | 0.0419 |
Onchocerca volvulus | 0.0155 | 0.6018 | 0.2726 | |
Loa Loa (eye worm) | VCP protein | 0.005 | 0.146 | 0.146 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.005 | 0.146 | 0.3227 |
Echinococcus granulosus | NADP dependent isocitrate dehydrogenase | 0.0016 | 0.0001 | 0.0003 |
Trypanosoma brucei | Valosin-containing protein | 0.0114 | 0.4256 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0026 | 0.0419 | 0.0983 |
Echinococcus granulosus | transitional endoplasmic reticulum atpase | 0.012 | 0.4525 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0026 | 0.0419 | 0.0419 |
Giardia lamblia | AAA family ATPase | 0.0072 | 0.2427 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by in vitro cell culture method | ChEMBL. | No reference | |
IC50 (functional) | > 50 ug ml-1 | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 by in vitro cell culture method | ChEMBL. | No reference |
IC50 (ADMET) | = 103.2 ug ml-1 | Cytotoxicity against Homo sapiens (human) K562 cells by Sulphorhodamine B assay | ChEMBL. | No reference |
IC80 (functional) | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 by in vitro cell culture method | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.